The image-guided therapy systems market is expected to grow from US$4.96 billion in 2024 to US$8.42 billion by 2033 at a 6.05% CAGR. Growth is tied to minimally invasive care, chronic disease demand, and advances in imaging, AI, and navigation systems.
The blood-brain barrier continues to block most treatments for glioblastoma and central nervous system diseases, with only 0.01% of biologic drugs reaching the brain. New intellectual property coverage and synthetic methods aim to address delivery challenges.
The Indian Health Service announced it will phase out mercury-containing dental amalgams by 2027, citing environmental and health concerns. The move affects roughly 2.8 million patients and aligns with global efforts to reduce mercury exposure.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07596563 |
Olfactory Cell Transplantation and Intensive Rehabilitation to Repair Chronic Spinal Cord Injury |
NOT_YET_RECRUITING | PHASE1 |
| NCT07070310 |
DELirium, Incidence, preVEntion and pRogression During Acute Intensive Neurological -Neurosurgical Rehabilitation |
NOT_YET_RECRUITING | |
| NCT07063810 |
NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study. |
NOT_YET_RECRUITING | NA |
| NCT06958523 |
Apple Health Study |
RECRUITING | |
| NCT06773169 |
IAMABLE: Implementation and Evaluation of an App for Evidence-Based Self-Management Rehabilitation Strategies |
RECRUITING | NA |
| NCT05443100 |
Impact of WBC on Patients With Metabolic or Neurological Diseases or Fibromyalgia (WBC-MeNeFi) |
RECRUITING | NA |
| NCT04958577 |
Clinic Waiting Room-based Study of Swahili Language Artificial Intelligence-driven Symptom Assessments in Tanzanian Primary Health Care Facilities |
UNKNOWN | |
| NCT01631604 |
Gait Characteristics Following a Fall |
UNKNOWN | NA |
| NCT00857922 |
Neurosciences Research Repository |
RECRUITING | |
| NCT00491894 |
Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions |
COMPLETED | PHASE3 |
